Hypertension and Neuropsychiatric Symptoms in Patients with Drug-Naïve Alzheimer’s Disease
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose Neuropsychiatric symptoms (NPS) such as anxiety, depression, and delusions affect up to 90% of all patients with Alzheimer’s disease (AD). NPS is associated with significant caregiver burden and patient distress. Given the severe burden of NPS in AD, it is critical to know potential modifiable risk factors of NPS in AD. This study explores the association between hypertension and NPS in patients with drug-naïve AD. Methods We reviewed medical records of 149 patients with AD with (n=80) and without (n=69) hypertension. NPS were assessed using the Korean version of Neuropsychiatric Inventory (K-NPI). Affective, psychotic, and behavior symptom clusters were assessed separately. Results The total score of K-NPI was not significantly different between patients with AD with and without hypertension. Among K-NPI domains, scores of depression/dysphoria (p=0.045), anxiety (p=0.022), and apathy/indifference (p=0.037) were significantly higher in patients with AD with hypertension. Systolic blood pressure (BP) was associated with higher total K-NPI and affective symptom cluster scores. Diastolic BP was associated with affective symptom cluster scores. Conclusions Results suggest that hypertension increases risk of specific NPS in patients with AD. Among NPS, hypertension was associated with affective symptom cluster.
Abstract
Background and Purpose Neuropsychiatric symptoms (NPS) such as anxiety, depression, and delusions affect up to 90% of all patients with Alzheimer’s disease (AD). NPS is associated with significant caregiver burden and patient distress. Given the severe burden of NPS in AD, it is critical to know potential modifiable risk factors of NPS in AD. This study explores the association between hypertension and NPS in patients with drug-naïve AD. Methods We reviewed medical records of 149 patients with AD with (n=80) and without (n=69) hypertension. NPS were assessed using the Korean version of Neuropsychiatric Inventory (K-NPI). Affective, psychotic, and behavior symptom clusters were assessed separately. Results The total score of K-NPI was not significantly different between patients with AD with and without hypertension. Among K-NPI domains, scores of depression/dysphoria (p=0.045), anxiety (p=0.022), and apathy/indifference (p=0.037) were significantly higher in patients with AD with hypertension. Systolic blood pressure (BP) was associated with higher total K-NPI and affective symptom cluster scores. Diastolic BP was associated with affective symptom cluster scores. Conclusions Results suggest that hypertension increases risk of specific NPS in patients with AD. Among NPS, hypertension was associated with affective symptom cluster.
참고문헌 (29)
- Fratiglioni L, "Worldwide prevalence and incidence of dementia", Drugs Aging, 15, pp.365~375 (1999)
- Kearney PM, "Global burden of hypertension: analysis of worldwide data", Lancet, 365, pp.217~223 (2005)
- Seux ML, "Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project", J Hypertens, 16, pp.963~969 (1998)
- Morris MC, "Association between blood pressure and cognitive function in a biracial community population of older persons", Neuroepidemiology, 21, pp.123~130 (2002)
- Waldstein SR, "Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging", Hypertension, 45, pp.374~379 (2005)
- Elias MF, "Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study", Am J Epidemiol, 138, pp.353~364 (1993)
- Kilander L, "Hypertension is related to cognitive impairment: a 20-year follow-up of 999men", Hypertension, 31, pp.780~786 (1998)
- Tzourio C, "Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging", Neurology, 53, pp.1948~1952 (1999)
- Knopman D, "Cardiovascular risk factors and cognitive decline in middle-aged adults", Neurology, 56, pp.42~48 (2001)
- Treiber KA, "Vascular factors and risk for neuropsychiatric symptoms in Alzheimer’s disease: the Cache County Study", Int Psychogeriatr, 20, pp.538~553 (2008)
- McKhann G, "Clinical diagnosis of Alzheimer’s disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
- Folstein MF, "'Mini-mental state.' A practical method for grading the cognitive state of patients for the clinician", J Psychiatr Res, 12, pp.189~198 (1975)
- Kang YW, "A validity study on the Korean minimental state examination (K-MMSE) in dementia patients", J Korean Neurol Assoc, 15, pp.300~308 (1997)
- Choi SH, "Estimating the validity of the Korean version of expanded clinical dementia rating (CDR) scale", J Korean Neurol Assoc, 19, pp.585~591 (2001)
- Choi SH, "The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients", J Korean Med Sci, 15, pp.609~615 (2000)
- Jutkowitz E, "Risk factors associated with cognitive, functional, and behavioral trajectories of newly diagnosed dementia patients", J Gerontol A Biol Sci Med Sci, 72, pp.251~258 (2017)
- Qiu C, "The age-dependent relation of blood pressure to cognitive function and dementia", Lancet Neurol, 4, pp.487~499 (2005)
- Steinberg M, "Vascular risk factors and neuropsychiatric symptoms in Alzheimer’s disease: the Cache County Study", Int J Geriatr Psychiatry, 29, pp.153~159 (2014)
- Lopez OL, "The psychotic phenomenon in probable Alzheimer’s disease: a positron emission tomography study", J Neuropsychiatry Clin Neurosci, 13, pp.50~55 (2001)
- O’Brien J, "The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms", Ann N Y Acad Sci, 903, pp.482~489 (2000)
- Faraco G, "Hypertension: a harbinger of stroke and dementia", Hypertension, 62, pp.810~817 (2013)
- Kivipelto M, "Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study", BMJ, 322, pp.1447~1451 (2001)
- Luchsinger JA, "Adiposity, type 2 diabetes, and Alzheimer’s disease", J Alzheimers Dis, 16, pp.693~704 (2009)
- Ahtiluoto S, "Diabetes, Alzheimer disease, and vascular dementia:a population-based neuropathologic study", Neurology, 75, pp.1195~1202 (2010)
- Zlokovic BV, "Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders", Nat Rev Neurosci, 12, pp.723~738 (2011)
- Qiu L, "Chronic cerebral hypoperfusion enhances Tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice", Sci Rep, 6, pp.23964~ (2016)
- Bennett SA, "Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion", Neurobiol Aging, 21, pp.207~214 (2000)
- Koike MA, "Oligemic hypoperfusion differentially affects tau and amyloid-β", Am J Pathol, 177, pp.300~310 (2010)
- Wang X, "Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats", J Alzheimers Dis, 21, pp.813~822 (2010)